Cargando…
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments
BACKGROUND: Symptom Screening in Pediatrics Tool (SSPedi) was developed for symptom screening by children 8-18 years. Objectives were to evaluate the reliability and validity of proxy-SSPedi and self-report mini-SSPedi for younger children. METHODS: This multi-center study enrolled guardians of chil...
Autores principales: | Tomlinson, Deborah, Dupuis, L. Lee, Johnston, Donna L., Kuczynski, Susan, Patel, Serina, Schechter, Tal, Vettese, Emily, Mairs, Mark, Tomlinson, George A., Sung, Lillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254487/ https://www.ncbi.nlm.nih.gov/pubmed/35787263 http://dx.doi.org/10.1186/s12885-022-09814-8 |
Ejemplares similares
-
Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
por: Tomlinson, Deborah, et al.
Publicado: (2019) -
Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)
por: O'Sullivan, C, et al.
Publicado: (2014) -
Discordance between pediatric self‐report and parent proxy‐report symptom scores and creation of a dyad symptom screening tool (co‐SSPedi)
por: Tomlinson, Deborah, et al.
Publicado: (2020) -
Translating the Symptom Screening in Pediatrics Tool (SSPedi) into French and among French-speaking children receiving cancer treatments, evaluating understandability and cultural relevance in a multiple-phase descriptive study
por: Larouche, Valérie, et al.
Publicado: (2020) -
Translating the Symptom Screening in Pediatrics Tool (SSPedi) into Argentinian Spanish for paediatric patients receiving cancer treatments, and evaluating understandability and cultural relevance in a multiple-phase descriptive study
por: Gomez, Sergio, et al.
Publicado: (2021)